BioPlus Acquisition Corp.
BIOS · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $260,733 | $245,966 | $6,109,434 | $294,557 |
| - Cash | $2 | $35 | $140 | $107 |
| + Debt | $5,250 | $5,000 | $5,000 | $5,000 |
| Enterprise Value | $265,981 | $250,931 | $6,114,294 | $299,450 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$1,171 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1,279 | -$275 | -$318 | -$290 |
| % Margin | – | – | – | – |
| Net Income | $1,241 | $2,321 | $1,574 | $659 |
| % Margin | – | – | – | – |
| EPS Diluted | 0.05 | 0.17 | 0.06 | 0.02 |
| % Growth | -70.6% | 185.7% | 197.5% | – |
| Operating Cash Flow | -$879 | -$316 | -$230 | -$188 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$879 | -$316 | -$230 | -$188 |